API

PLI Scheme for Bulk Drug Manufacturing 2025 – New Subsidy Guidelines

by
PLI Scheme for Bulk Drug Manufacturing 2025 – New Subsidy Guidelines

The Government of India has updated the Bulk Drug Production Linked Incentive Scheme 2025, providing revised subsidies and guidelines for the manufacturing of critical Active Pharmaceutical Ingredients (APIs) within the country. This initiative supports the “Atmanirbhar Bharat” mission by reducing import dependency and boosting local pharmaceutical manufacturing. With the 2025 update, the scheme offers more … Read more

API Import Duty Change from August 2025 – Impact on Pharma Industry

by
API Import Duty Change from August 2025 – Impact on Pharma Industry

The Government of India has officially announced a significant change in API Import Duty India 2025, effective from August. This move is a part of the larger policy to promote domestic manufacturing of Active Pharmaceutical Ingredients (APIs) under the Atmanirbhar Bharat initiative. The updated duty structure introduces increased import tariffs on over 40 high-demand APIs, … Read more